# BHARAT V. DAFTARY

> BHARAT V. DAFTARY is a private equity investor at Bharat Serums and Vaccines backing Medical. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Bharat Serums and Vaccines](https://shizune.co/investors/profile/bharat-serums-and-vaccines-limited)
- Location: Mumbai, India
- Total investments: 1
- Last investment: Nov 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/bharat-daftary-0004459/?originalSubdomain=in

BHARAT V. DAFTARY is a private equity investor at Bharat Serums and Vaccines in Mumbai focused on Medical and Health Care. Mr. Bharat V. Daftary, Chairman and Managing Director of the Company, has been involved with the business affairs of the Company since over three decades. He plays an important role in the marketing function and in development of global relationships. He spearheads the strategic planning of the Company. He is related to Dr. Gautam Daftary, ViceChairman and Managing Director of the Company and Mr. Siddharth B. Daftary, Whole-time Director of the Company

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Rivaara Labs | Rivaara Labs offers molecular diagnostics services and various clinical testing solutions. The company is dedicated to the establishment of a large network of specialized Molecular Diagnostics labs, a best-in-class national reference lab, and the marketing of novel Point Of Care (POC) solutions. Its solutions address a significant unmet medicalneed for timely, actionable information that addresses the challenges of the current standard of care for diagnosing and monitoring diseases. Rivaara Labs' open, dynamic, and collaborative culture enables teams to deliver innovation to healthcare professionals and patients. | $7.3M | Private Equity | Nov 07, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Amicus Capital](https://shizune.co/investors/profile/amicus-capital-2) — VC Fund, 1 deal together
- [Kotak Alternate Asset Managers](https://shizune.co/investors/profile/kotak-investment-advisors) — VC Fund, 1 deal together

## About Bharat Serums and Vaccines

VC Fund · Mumbai, India

Bharat Serums and Vaccines is a biopharmaceutical company focused on creating innovative treatments in women's health and critical care. The company offers a diverse range of products, including plasma derivatives and monoclonal antibodies, aimed at addressing various medical conditions. With a strong emphasis on research and development,Bharat Serums and Vaccines strives to enhance accessibility and improve patient outcomes globally.

5 contacts available at Bharat Serums and Vaccines.

| Name | Title | Profile |
| --- | --- | --- |
| BHARAT V. DAFTARY | Chairman & Managing Director | https://shizune.co/investors/profile/bharat-v-daftary |
| Chirag Mehta | Chief Financial Officer | https://shizune.co/investors/profile/chirag-mehta-a9d5 |
| Gautam Daftary | Vice Chairman & Managing Director | https://shizune.co/investors/profile/gautam-daftary |
| Nilesh Kulkarni | Chief Human Resource Officer | https://shizune.co/investors/profile/nilesh-kulkarni-e4df |
| Rahul Adakmol | COO (International Operations & Business Development) | https://shizune.co/investors/profile/rahul-adakmol |

## Similar investors

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

## FAQ

### What does BHARAT V. DAFTARY invest in?

BHARAT V. DAFTARY invests primarily in Medical, Health Care and Biotechnology startups, most often at Private Equity stage. Most of the 1 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did BHARAT V. DAFTARY last invest?

The most recent investment recorded for BHARAT V. DAFTARY closed in Nov 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co